167 related articles for article (PubMed ID: 27553688)
1. Comparison of different normalization strategies for the analysis of glomerular microRNAs in IgA nephropathy.
Bockmeyer CL; Säuberlich K; Wittig J; Eßer M; Roeder SS; Vester U; Hoyer PF; Agustian PA; Zeuschner P; Amann K; Daniel C; Becker JU
Sci Rep; 2016 Aug; 6():31992. PubMed ID: 27553688
[TBL] [Abstract][Full Text] [Related]
2. ANCA-associated crescentic glomerulonephritis with mesangial IgA deposits.
Haas M; Jafri J; Bartosh SM; Karp SL; Adler SG; Meehan SM
Am J Kidney Dis; 2000 Oct; 36(4):709-18. PubMed ID: 11007672
[TBL] [Abstract][Full Text] [Related]
3. Glomerular morphometry of twenty-three biopsied patients with IgA nephropathy.
Biondo B; Grosso E; Fogato E; Giordano F; Matturri L
Am J Nephrol; 1995; 15(2):99-104. PubMed ID: 7733163
[TBL] [Abstract][Full Text] [Related]
4. Histology and immunohistology of IgA nephropathy.
Haas M
J Nephrol; 2005; 18(6):676-80. PubMed ID: 16358224
[TBL] [Abstract][Full Text] [Related]
5. Selection and validation of endogenous controls for microRNA expression studies in endometrioid endometrial cancer tissues.
Torres A; Torres K; Wdowiak P; Paszkowski T; Maciejewski R
Gynecol Oncol; 2013 Sep; 130(3):588-94. PubMed ID: 23811003
[TBL] [Abstract][Full Text] [Related]
6. Intrarenal expression of microRNAs in patients with IgA nephropathy.
Wang G; Kwan BC; Lai FM; Choi PC; Chow KM; Li PK; Szeto CC
Lab Invest; 2010 Jan; 90(1):98-103. PubMed ID: 19901913
[TBL] [Abstract][Full Text] [Related]
7. MicroRNAs in IgA nephropathy.
Szeto CC; Li PK
Nat Rev Nephrol; 2014 May; 10(5):249-56. PubMed ID: 24709842
[TBL] [Abstract][Full Text] [Related]
8. Identification of stably expressed reference small non-coding RNAs for microRNA quantification in high-grade serous ovarian carcinoma tissues.
Bignotti E; Calza S; Tassi RA; Zanotti L; Bandiera E; Sartori E; Odicino FE; Ravaggi A; Todeschini P; Romani C
J Cell Mol Med; 2016 Dec; 20(12):2341-2348. PubMed ID: 27419385
[TBL] [Abstract][Full Text] [Related]
9. Detection of microRNA Expression in the Kidneys of Immunoglobulin a Nephropathic Mice.
Kaneko S; Yanai K; Ishii H; Aomatsu A; Ito K; Hirai K; Ookawara S; Ishibashi K; Morishita Y
J Vis Exp; 2020 Jul; (161):. PubMed ID: 32716396
[TBL] [Abstract][Full Text] [Related]
10. Local macrophage proliferation in human glomerulonephritis.
Yang N; Isbel NM; Nikolic-Paterson DJ; Li Y; Ye R; Atkins RC; Lan HY
Kidney Int; 1998 Jul; 54(1):143-51. PubMed ID: 9648072
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology of biopsy-proven glomerulonephritis in Queensland adults.
Jegatheesan D; Nath K; Reyaldeen R; Sivasuthan G; John GT; Francis L; Rajmokan M; Ranganathan D
Nephrology (Carlton); 2016 Jan; 21(1):28-34. PubMed ID: 26154936
[TBL] [Abstract][Full Text] [Related]
12. Small nucleolar RNA U91 is a new internal control for accurate microRNAs quantification in pancreatic cancer.
Popov A; Szabo A; Mandys V
BMC Cancer; 2015 Oct; 15():774. PubMed ID: 26499892
[TBL] [Abstract][Full Text] [Related]
13. Urinary exosomal miRNA signature of IgA nephropathy: a case-control study.
Shankar M; Shetty A; N S M; C G S; A K; Tennankore K
Sci Rep; 2023 Dec; 13(1):21400. PubMed ID: 38049447
[TBL] [Abstract][Full Text] [Related]
14. U6 can be used as a housekeeping gene for urinary sediment miRNA studies of IgA nephropathy.
Duan ZY; Cai GY; Li JJ; Bu R; Wang N; Yin P; Chen XM
Sci Rep; 2018 Jul; 8(1):10875. PubMed ID: 30022109
[TBL] [Abstract][Full Text] [Related]
15. Mononuclear cell activation and decreased renal function in IgA nephropathy with crescents.
Li HL; Hancock WW; Hooke DH; Dowling JP; Atkins RC
Kidney Int; 1990 Jun; 37(6):1552-6. PubMed ID: 2362407
[TBL] [Abstract][Full Text] [Related]
16. Interstitial inflammatory and chronic tubulointerstitial lesions in lupus nephritis: comparison with those in IgA nephropathy.
Yamamoto T; Nagase M; Hishida A; Honda N
Lupus; 1993 Aug; 2(4):261-8. PubMed ID: 8268975
[TBL] [Abstract][Full Text] [Related]
17. Glomerular capillary and endothelial cell injury is associated with the formation of necrotizing and crescentic lesions in crescentic glomerulonephritis.
Fujita E; Nagahama K; Shimizu A; Aoki M; Higo S; Yasuda F; Mii A; Fukui M; Kaneko T; Tsuruoka S
J Nippon Med Sch; 2015; 82(1):27-35. PubMed ID: 25797872
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of microRNA miR-150-5p in IgA nephropathy as a potential mediator and marker of disease progression.
Pawluczyk IZA; Didangelos A; Barbour SJ; Er L; Becker JU; Martin R; Taylor S; Bhachu JS; Lyons EG; Jenkins RH; Fraser D; Molyneux K; Perales-Patón J; Saez-Rodriguez J; Barratt J
Kidney Int; 2021 May; 99(5):1127-1139. PubMed ID: 33417998
[TBL] [Abstract][Full Text] [Related]
19. Crescentic glomerulonephritis: a clinicopathologic analysis of 17 cases with emphasis on glomerular and interstitial neutrophil infiltration.
Suh KS; Kim BK; Kim KH
J Korean Med Sci; 1999 Jun; 14(3):293-8. PubMed ID: 10402172
[TBL] [Abstract][Full Text] [Related]
20. [Expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in IgA nephropathy].
Wang J; Chen X; Shi S; Zhang Y; Tian Y
Zhonghua Nei Ke Za Zhi; 2002 Feb; 41(2):75-8. PubMed ID: 11940298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
